Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | PSMD14 | O00487 | 2/20 | 0.36 |
| ▸ | PLA2G1B | P04054 | 2/20 | 0.36 |
| ▸ | MMP2 | P08253 | 2/20 | 0.36 |
| ▸ | ATG4B | Q9Y4P1 | 2/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | RAD52 | P43351 | 1/20 | 0.32 |
| ▸ | SLC22A16 | Q86VW1 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16405718 | 0.95 | MAPT (0.44) | MAPTPSMD14PLA2G1BMMP2ATG4B | |
| SCHEMBL12931451 | 0.92 | PSMD14 (0.33) | MAPTPSMD14PLA2G1BMMP2ATG4B | |
| SCHEMBL15099704 | 0.87 | LMNA (0.38) | MAPTPSMD14PLA2G1BMMP2ATG4B | |
| SCHEMBL12192711 | 0.86 | PSMD14 (0.35) | MAPTPSMD14PLA2G1BMMP2ATG4B | |
| Water SCHEMBL28099902 | 0.83 | PSMD14 (0.34) | MAPTPSMD14PLA2G1BMMP2ATG4B | |
| SCHEMBL10274560 | 0.81 | — | — | |
| SCHEMBL890513 | 0.81 | — | — | |
| SCHEMBL13380702 | 0.81 | MAPT (0.52) | MAPTPSMD14PLA2G1BMMP2ATG4B | |
| SCHEMBL12967918 | 0.81 | PSMD14 (0.33) | PSMD14PLA2G1BMMP2ATG4BHSP90AA1 | |
| Water SCHEMBL1358117 | 0.79 | MAPT (0.44) | MAPTTSHRSLC22A16 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9328200-B2 | Branched polymeric quaternary ammonium compounds and their uses | ULTRASCI DISCOVERY LLP (US) | 2016-05-03 | — | — | US | disclosed |
| US-9328200-B2 | Branched polymeric quaternary ammonium compounds and their uses | ULTRASCI DISCOVERY LLP (US) | 2016-05-03 | — | — | US | disclosed |
| US-20160009861-A1 | Branched Polymeric Quaternary Ammonium Compounds and Their Uses | CHEN HWANG-HSING (US) | 2016-01-14 | — | — | US | disclosed |
| US-20160009861-A1 | Branched Polymeric Quaternary Ammonium Compounds and Their Uses | CHEN HWANG-HSING (US) | 2016-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160009861-A1 | Branched Polymeric Quaternary Ammonium Compounds and Their Uses | BCAT2, UACA, BCAT1 | MAPT 1143/4885PSMD14 1032/4885PLA2G1B 4265/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.